In a Raji B-cell lymphoma model of NOD-SCID IL2Rγnull (NSG) mice, NK-92 cells were engineered by lentivirus to express CARs targeting CD19, inhibiting cancer progression [110]. The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.